Employers are spending more on the treatment of heart disease than any other chronic disease and there is mounting evidence that the wrong treatments are being utilized.
Conventional medicine insists that cholesterol is the primary factor in determining our risk of heart disease, and that statin drugs are the No. 1 defense against this risk. However, what if there is insufficient scientific evidence to support this proposition? And what if this approach is actually causing serious health problems, simply because of the stubbornness of the medical community and the profits being made by the pharmaceutical and hospital sectors? Continue reading